A Plus Biotechnology Co (6918.TWO) Stock Price
A Plus Biotechnology Co Price
Over the last 5 years A Plus Biotechnology Co grew revenue by 10.2% annually, reaching 769.59 M TWD. Earnings per share have grown at 37.2% per year over the last 5 years. For A Plus Biotechnology Co, the net margin of 19.6% is up versus 7.2% a few years ago. At today's price the dividend yield works out to roughly 3.61%. The payout ratio is around 55% of earnings.
A Plus Biotechnology Co stock price
A Plus Biotechnology Co business model & stock analysis
Frequently asked questions about A Plus Biotechnology Co
Converted at the current exchange rate, the A Plus Biotechnology Co share trades at 2.11 EUR (75.50 TWD).
The revenue cannot currently be calculated for A Plus Biotechnology Co.
The profit cannot currently be calculated for A Plus Biotechnology Co.
The P/E ratio cannot be calculated for A Plus Biotechnology Co at the moment.
The P/S cannot be calculated for A Plus Biotechnology Co currently.
The Eulerpool Quality Score for A Plus Biotechnology Co is 4/10.
The ISIN of A Plus Biotechnology Co is TW0006918006. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of A Plus Biotechnology Co is 6918.TWO. The ticker symbol is used to trade A Plus Biotechnology Co shares on the stock exchange.
A Plus Biotechnology Co stock
A Plus Biotechnology Co Peer Group
A Plus Biotechnology Co FIGI
All fundamentals and in-depth analysis of A Plus Biotechnology Co
Our stock analysis for A Plus Biotechnology Co stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of A Plus Biotechnology Co. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.